About 50 to 60 percent of men and women with alcohol dependence abstain or show substantial improvement in a year after treatment, which can include drugs such as Forest Laboratories Inc's Campral or acamprosate, naltrexone, also known as Revia and Depade, and disulfiramacamprosate or Antabuse.